105 related articles for article (PubMed ID: 22985482)
1. Homology models of human all-trans retinoic acid metabolizing enzymes CYP26B1 and CYP26B1 spliced variant.
Saenz-Méndez P; Elmabsout AA; Sävenstrand H; Awadalla MK; Strid Å; Sirsjö A; Eriksson LA
J Chem Inf Model; 2012 Oct; 52(10):2631-7. PubMed ID: 22985482
[TBL] [Abstract][Full Text] [Related]
2. Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents.
Sun B; Song S; Hao CZ; Huang WX; Liu CC; Xie HL; Lin B; Cheng MS; Zhao DM
J Mol Graph Model; 2015 Mar; 56():10-9. PubMed ID: 25541526
[TBL] [Abstract][Full Text] [Related]
3. Improved Homology Model of the Human all-trans Retinoic Acid Metabolizing Enzyme CYP26A1.
Awadalla MK; Alshammari TM; Eriksson LA; Saenz-Méndez P
Molecules; 2016 Mar; 21(3):351. PubMed ID: 26999080
[TBL] [Abstract][Full Text] [Related]
4. Homology Models and Molecular Modeling of Human Retinoic Acid Metabolizing Enzymes Cytochrome P450 26A1 (CYP26A1) and P450 26B1 (CYP26B1).
Karlsson M; Strid Å; Sirsjö A; Eriksson LA
J Chem Theory Comput; 2008 Jun; 4(6):1021-7. PubMed ID: 26621242
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of substrate-free and retinoic acid-bound cyanobacterial cytochrome P450 CYP120A1.
Kühnel K; Ke N; Cryle MJ; Sligar SG; Schuler MA; Schlichting I
Biochemistry; 2008 Jun; 47(25):6552-9. PubMed ID: 18512957
[TBL] [Abstract][Full Text] [Related]
6. Cloning and functional studies of a splice variant of CYP26B1 expressed in vascular cells.
Elmabsout AA; Kumawat A; Saenz-Méndez P; Krivospitskaya O; Sävenstrand H; Olofsson PS; Eriksson LA; Strid A; Valen G; Törmä H; Sirsjö A
PLoS One; 2012; 7(5):e36839. PubMed ID: 22666329
[TBL] [Abstract][Full Text] [Related]
7. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.
Foti RS; Isoherranen N; Zelter A; Dickmann LJ; Buttrick BR; Diaz P; Douguet D
J Pharmacol Exp Ther; 2016 May; 357(2):281-92. PubMed ID: 26937021
[TBL] [Abstract][Full Text] [Related]
8. CYP26B1 plays a major role in the regulation of all-trans-retinoic acid metabolism and signaling in human aortic smooth muscle cells.
Ocaya PA; Elmabsout AA; Olofsson PS; Törmä H; Gidlöf AC; Sirsjö A
J Vasc Res; 2011; 48(1):23-30. PubMed ID: 20606468
[TBL] [Abstract][Full Text] [Related]
9. Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding.
Gomaa MS; Yee SW; Milbourne CE; Barbera MC; Simons C; Brancale A
J Enzyme Inhib Med Chem; 2006 Aug; 21(4):361-9. PubMed ID: 17059167
[TBL] [Abstract][Full Text] [Related]
10. Direct protein-protein interactions and substrate channeling between cellular retinoic acid binding proteins and CYP26B1.
Nelson CH; Peng CC; Lutz JD; Yeung CK; Zelter A; Isoherranen N
FEBS Lett; 2016 Aug; 590(16):2527-35. PubMed ID: 27416800
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of Synechocystis CYP120A1 revealed the first nonanimal retinoic acid hydroxylase.
Alder A; Bigler P; Werck-Reichhart D; Al-Babili S
FEBS J; 2009 Oct; 276(19):5416-31. PubMed ID: 19703230
[TBL] [Abstract][Full Text] [Related]
12. Prospective teratology of retinoic acid metabolic blocking agents (RAMBAs) and loss of CYP26 activity.
McCaffery P; Simons C
Curr Pharm Des; 2007; 13(29):3020-37. PubMed ID: 17979744
[TBL] [Abstract][Full Text] [Related]
13. Novel tetralone-derived retinoic acid metabolism blocking agents: synthesis and in vitro evaluation with liver microsomal and MCF-7 CYP26A1 cell assays.
Yee SW; Jarno L; Gomaa MS; Elford C; Ooi LL; Coogan MP; McClelland R; Nicholson RI; Evans BA; Brancale A; Simons C
J Med Chem; 2005 Nov; 48(23):7123-31. PubMed ID: 16279770
[TBL] [Abstract][Full Text] [Related]
14. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid.
Taimi M; Helvig C; Wisniewski J; Ramshaw H; White J; Amad M; Korczak B; Petkovich M
J Biol Chem; 2004 Jan; 279(1):77-85. PubMed ID: 14532297
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the
Stevison F; Hogarth C; Tripathy S; Kent T; Isoherranen N
Drug Metab Dispos; 2017 Jul; 45(7):846-854. PubMed ID: 28446509
[No Abstract] [Full Text] [Related]
16. A variant in CYP26B1 associated with esophageal squamous cell carcinoma risk by affecting retinoic acid metabolism.
Niu S; Shi K; Yue X; Pan M; Song L; Gu L; Tan Y; Miao X; Tian J; Chang J
Mol Carcinog; 2023 Jul; 62(7):991-1000. PubMed ID: 37042568
[TBL] [Abstract][Full Text] [Related]
17. Exogenous retinoic acid and cytochrome P450 26B1 inhibitor modulate meiosis-associated genes expression in canine testis, an in vitro model.
Kasimanickam V; Kasimanickam R
Reprod Domest Anim; 2014 Apr; 49(2):315-23. PubMed ID: 24467691
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.
Pavez Loriè E; Cools M; Borgers M; Wouters L; Shroot B; Hagforsen E; Törmä H; Vahlquist A
Br J Dermatol; 2009 Jan; 160(1):26-36. PubMed ID: 19016711
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases.
Topletz AR; Thatcher JE; Zelter A; Lutz JD; Tay S; Nelson WL; Isoherranen N
Biochem Pharmacol; 2012 Jan; 83(1):149-63. PubMed ID: 22020119
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.
Foti RS; Diaz P; Douguet D
J Enzyme Inhib Med Chem; 2016; 31(sup2):148-161. PubMed ID: 27424662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
